We are live on
!
Find out more
SELLAS Life Sciences
160 hedge funds and large institutions have $228M invested in SELLAS Life Sciences in 2026 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 53 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
806% more call options, than puts
Call options by funds: $102M | Put options by funds: $11.3M
347% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 15
194% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 18
71% more capital invested
Capital invested by funds: $134M → $228M (+$94.7M)
43% more funds holding
Funds holding: 112 → 160 (+48)
5.16% more ownership
Funds ownership: 24.89% → 30.05% (+5.2%)
Holders
160
Holders Change
+48
Holders Change %
+42.86%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
67
Increased
53
Reduced
18
Closed
15
Calls
$102M
Puts
$11.3M
Net Calls
+$90.7M
Net Calls Change
+$18.2M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$27.8M |
| 2 |
BlackRock
New York
|
+$20.8M |
| 3 |
Jones Financial Companies
Des Peres,
Missouri
|
+$5.57M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.74M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.12M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$5.5M |
| 2 |
Two Sigma Investments
New York
|
-$3.04M |
| 3 |
Barclays
London,
United Kingdom
|
-$2.14M |
| 4 |
CS
Clear Street
New York
|
-$1.89M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.58M |
